Biblioteca CRAI Dulce Chacón - Universidad Europea de Madrid

CRAI Library - Madrid
Your cart is empty.
My folder ( items) | My account
Image from Google Jackets

Manual of cardio-oncology : cardiovascular care in the cancer patient / Chiara Lestuzzi, Stefano Oliva, Francesco Ferraù, editors.

Contributor(s): Ferraù, Francesco,, editor literario | Lestuzzi, Chiara,, editor literario | Oliva, Stefano,, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Springer International Publishing, 2017Description: 1 recurso en línea.ISBN: 331940234X; 3319402366; 9783319402345; 9783319402369.Subject: Cancer -- ComplicationsOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
""Foreword""; ""Contents""; ""List of Contributors""; ""I: Introductory Aspects""; ""1: Epidemiology of Cancer: Prevalence, Incidence of Neoplastic Diseases and Trends in Survival in Europe""; ""1.1 Background""; ""1.2 Cancer Distribution""; ""1.2.1 Incidence of All Cancers Excluding Nonmelanoma Skin Cancers""; ""1.2.2 Mortality of All Cancers Excluding Nonmelanoma Skin Cancers""; ""1.3 Lung Cancer""; ""1.3.1 Incidence""; ""1.3.2 Mortality""; ""1.3.3 Risk Factors""; ""1.3.4 Survival""; ""1.4 Breast Cancer""; ""1.4.1 Incidence""; ""1.4.2 Mortality""
""1.4.3 Risk Factors""""1.4.4 Survival""; ""1.5 Colorectal Cancer""; ""1.5.1 Incidence""; ""1.5.2 Mortality""; ""1.5.3 Risk Factors""; ""1.5.4 Survival""; ""1.6 Prostate Cancer""; ""1.6.1 Incidence""; ""1.6.2 Mortality""; ""1.6.3 Risk Factors""; ""1.6.4 Survival""; ""1.7 Discussion""; ""1.8 European Code Against Cancer""; ""References""; ""2: Cancer, Heart Diseases, and Common Risk Factors: Smoke""; ""2.1 Key Points""; ""2.2 Epidemiology""; ""2.3 Cigarette Smoke: Chemicalâ#x80;#x93;Physical Characteristics""; ""2.4 Pathophysiology""
""2.5 Smoke as Risk Factor for Cancer and Other Diseases""""2.6 Conclusions""; ""References""; ""3: Cancer, Heart Diseases and Common Risk Factors: Diet and Physical Activity""; ""3.1 Background""; ""3.2 Diet""; ""3.2.1 Dietary Supplements""; ""3.2.2 Prevention of Cardiotoxicity""; ""3.2.3 Traditional and Alternative Dietary Patterns (. Table 3.1)""; ""3.3 Physical Activity""; ""3.3.1 Physical Activity and Cardiovascular Diseases""; ""3.3.2 Physical Activity in Cancer Prevention (. Fig.  3.5)""; ""3.3.3 Physical Activity After Cancer Diagnosis""
""3.3.4 Cardiovascular Disease, Cancer, and Physical Activity""""References""; ""II: Cardiac Problems as a Consequence of Cancer""; ""4: Thromboembolic Disorders as a Consequence of Cancer""; ""4.1 Introduction""; ""4.2 Clinical Aspects""; ""4.3 Screening for Occult Cancer in Patients with Idiopathic VTE""; ""4.4 Primary Thromboprophylaxis and Identification of High-Risk Outpatients""; ""4.4.1 Surgical Prophylaxis""; ""4.4.2 High-Risk Cancer Outpatients Identification for Primary Thromboprophylaxis""; ""4.4.3 Multiple Myeloma""
""4.5 Appropriate Immediate and Long-Term Treatment for Patients with Acute Thromboembolism and the Role of NOACs""""4.5.1 Acute Treatment (First 10 Days)""; ""4.5.2 Long-Term (First 3 Months) and Extended Therapy (No Planned Stop Date)""; ""4.5.3 Treatment of Catheter-Related DVT""; ""4.5.4 Vena Cava Filters""; ""4.6 Management of Recurrent VTE on Anticoagulation Therapy [55, 63â#x80;#x93;67]""; ""4.7 Treatment Strategy in Patients with Thrombocytopenia""; ""References""; "" Suggested Reading: Society Guidelines""
Abstract: This concise and handy manual provides straightforward, up-to-date guidance for cardiologists and other practitioners on the management of cancer patients with cardiac problems, whether they be due to the cancer itself or to antineoplastic treatment. Detailed attention is devoted to the various forms of cardiotoxicity associated with chemotherapy and radiotherapy. The drugs commonly responsible for each toxicity are identified and clear advice is offered on monitoring techniques and treatment approaches. In addition, the issue of cardiotoxicity due to cancer treatment in particular patient groups - children, the elderly, and those with pre-existing cardiac disease - is addressed separately, with guidance on when and how antineoplastic (and/or cardiological) treatments should be modified. Further sections describe the correct responses to cardiac problems secondary to the cancer itself, including thromboembolic disorders and electrolyte imbalances, and the diagnosis, treatment, and follow-up of cardiac tumors. A closing section considers how to improve cooperation between oncologists, cardiologists, and general practitioners to ensure that cancer patients' cardiovascular needs are met in a multidisciplinary approach.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC669 2017 EB (Browse shelf(Opens below)) Acceso electrónico eBook.20024218
Total holds: 0

Incluye referencias bibliográficas

""Foreword""; ""Contents""; ""List of Contributors""; ""I: Introductory Aspects""; ""1: Epidemiology of Cancer: Prevalence, Incidence of Neoplastic Diseases and Trends in Survival in Europe""; ""1.1 Background""; ""1.2 Cancer Distribution""; ""1.2.1 Incidence of All Cancers Excluding Nonmelanoma Skin Cancers""; ""1.2.2 Mortality of All Cancers Excluding Nonmelanoma Skin Cancers""; ""1.3 Lung Cancer""; ""1.3.1 Incidence""; ""1.3.2 Mortality""; ""1.3.3 Risk Factors""; ""1.3.4 Survival""; ""1.4 Breast Cancer""; ""1.4.1 Incidence""; ""1.4.2 Mortality""

""1.4.3 Risk Factors""""1.4.4 Survival""; ""1.5 Colorectal Cancer""; ""1.5.1 Incidence""; ""1.5.2 Mortality""; ""1.5.3 Risk Factors""; ""1.5.4 Survival""; ""1.6 Prostate Cancer""; ""1.6.1 Incidence""; ""1.6.2 Mortality""; ""1.6.3 Risk Factors""; ""1.6.4 Survival""; ""1.7 Discussion""; ""1.8 European Code Against Cancer""; ""References""; ""2: Cancer, Heart Diseases, and Common Risk Factors: Smoke""; ""2.1 Key Points""; ""2.2 Epidemiology""; ""2.3 Cigarette Smoke: Chemicalâ#x80;#x93;Physical Characteristics""; ""2.4 Pathophysiology""

""2.5 Smoke as Risk Factor for Cancer and Other Diseases""""2.6 Conclusions""; ""References""; ""3: Cancer, Heart Diseases and Common Risk Factors: Diet and Physical Activity""; ""3.1 Background""; ""3.2 Diet""; ""3.2.1 Dietary Supplements""; ""3.2.2 Prevention of Cardiotoxicity""; ""3.2.3 Traditional and Alternative Dietary Patterns (. Table 3.1)""; ""3.3 Physical Activity""; ""3.3.1 Physical Activity and Cardiovascular Diseases""; ""3.3.2 Physical Activity in Cancer Prevention (. Fig.  3.5)""; ""3.3.3 Physical Activity After Cancer Diagnosis""

""3.3.4 Cardiovascular Disease, Cancer, and Physical Activity""""References""; ""II: Cardiac Problems as a Consequence of Cancer""; ""4: Thromboembolic Disorders as a Consequence of Cancer""; ""4.1 Introduction""; ""4.2 Clinical Aspects""; ""4.3 Screening for Occult Cancer in Patients with Idiopathic VTE""; ""4.4 Primary Thromboprophylaxis and Identification of High-Risk Outpatients""; ""4.4.1 Surgical Prophylaxis""; ""4.4.2 High-Risk Cancer Outpatients Identification for Primary Thromboprophylaxis""; ""4.4.3 Multiple Myeloma""

""4.5 Appropriate Immediate and Long-Term Treatment for Patients with Acute Thromboembolism and the Role of NOACs""""4.5.1 Acute Treatment (First 10 Days)""; ""4.5.2 Long-Term (First 3 Months) and Extended Therapy (No Planned Stop Date)""; ""4.5.3 Treatment of Catheter-Related DVT""; ""4.5.4 Vena Cava Filters""; ""4.6 Management of Recurrent VTE on Anticoagulation Therapy [55, 63â#x80;#x93;67]""; ""4.7 Treatment Strategy in Patients with Thrombocytopenia""; ""References""; "" Suggested Reading: Society Guidelines""

This concise and handy manual provides straightforward, up-to-date guidance for cardiologists and other practitioners on the management of cancer patients with cardiac problems, whether they be due to the cancer itself or to antineoplastic treatment. Detailed attention is devoted to the various forms of cardiotoxicity associated with chemotherapy and radiotherapy. The drugs commonly responsible for each toxicity are identified and clear advice is offered on monitoring techniques and treatment approaches. In addition, the issue of cardiotoxicity due to cancer treatment in particular patient groups - children, the elderly, and those with pre-existing cardiac disease - is addressed separately, with guidance on when and how antineoplastic (and/or cardiological) treatments should be modified. Further sections describe the correct responses to cardiac problems secondary to the cancer itself, including thromboembolic disorders and electrolyte imbalances, and the diagnosis, treatment, and follow-up of cardiac tumors. A closing section considers how to improve cooperation between oncologists, cardiologists, and general practitioners to ensure that cancer patients' cardiovascular needs are met in a multidisciplinary approach.

There are no comments on this title.

to post a comment.
Share